REPL Stock Analysis: Buy, Sell, or Hold?
REPL - Replimune Group, Inc.
$14.77
0.72 (5.12%)
▲
5d:
-1.34%
30d:
+37.4%
90d:
+186.24%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 20, 2026
0d
Get Alerted When REPL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: REPL shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: REPL shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: REPL is currently trading at $14.77, which is considered extended relative to its 30-day fair value range of $9.02 to $14.38.
Technical Outlook: Technically, REPL is in a strong uptrend. Immediate support is located at $12.27, while resistance sits at $15.71. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: REPL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.33 (+30.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, REPL is in a strong uptrend. Immediate support is located at $12.27, while resistance sits at $15.71. The stock is showing strong short-term momentum, up 5.1% recently.
Market Sentiment: REPL scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.33 (+30.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.02 -
$14.38
Company Quality Score
30/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.6%
Protect Your Profits
Holding REPL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.1%)
- BULLISH: Trading 30.9% below Wall St target ($19.33)
- WARNING: Composite score 30/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.02 -
$14.38
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$12.27
Resistance Level
$15.71
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.08
Wall Street Target
$19.33
(+30.9%)
Share & Embed Analysis
Last updated: August 23, 2026 1:10 AM ET
Data refreshes hourly during market hours. Next update: 2:10 AM
Data refreshes hourly during market hours. Next update: 2:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is REPL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Sarchi
SELL
6500 shares
2026-04-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$109 | 66 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 41 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 41 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 49 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 40 SELL |
Advanced REPL Option Strategies
Professional options setups generated by AI based on today's REPL price and gamma walls.
